GSI 7977 (Sovaldi 400 mg)

Generic Name: sofosbuvir

Pill imprint GSI 7977 has been identified as Sovaldi 400 mg.

Sovaldi is used in the treatment of hepatitis c and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. In combination with Ribavirin or Peginterferon Alfa/Ribavirin: Not for use in pregnancy. Sovaldi 400 mg Unknown

See also related documents.

Images for GSI 7977 (Sovaldi 400 mg)

Sovaldi 400 mg GSI 7977
Sovaldi
Generic Name:
sofosbuvir
Imprint:
GSI
7977
Strength:
400 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
X - Not for use in pregnancy - in combination with Ribavirin or Peginterferon Alfa/Ribavirin
CSA Schedule:
U - Unknown
Manufacturer:
Gilead Sciences, Inc.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)